Browse regulations

Transitional regulations establishing the Construction Industry Development Agency, creating a government body to oversee and develop Australia's construction industry through coordination, standards, and industry development initiatives.

Construction is fundamentally a market-driven sector where government intervention distorts price signals, creates bureaucratic overhead, and interferes with private sector innovation. The costs of maintaining this agency include regulatory duplication, compliance burdens on businesses, and displacement of market-led solutions to industry challenges. The construction industry would be more efficient, innovative, and responsive to consumer needs without this top-down government intervention.

Amends regulations governing the Australian Film, Television and Radio School (AFTRS) to update operational requirements and funding parameters

AFTRS provides essential training for Australia's creative industries; deleting it would reduce skilled workforce availability, harming national competitiveness in media production and cultural exports, with no viable alternative for specialized education in these sectors.

Amends the allowances regulations for the Australian Film, Television and Radio School, specifying payment rates and eligibility for certain allowances.

Creates bureaucratic overhead for a niche institution; allowance matters could be managed internally or under broader public service rules without loss of prosperity or liberty.

Regulates approval, monitoring, and safety standards for therapeutic goods including medicines and medical devices to ensure public health protection

Regulatory burden adds billions in compliance costs without proportional health benefits, stifles medical innovation, and creates barriers to accessing life-saving treatments while failing to demonstrably improve public health outcomes compared to market-based alternatives.

Amends the Therapeutic Goods Regulations to update standards and compliance requirements for therapeutic goods in Australia.

Removing it would eliminate safety oversight and consumer protection for therapeutic goods, likely increasing health risks and reducing public confidence.

Amendment to the Therapeutic Goods Regulations 2002, modifying requirements for the registration, listing, and approval of therapeutic goods (medicines, medical devices, and other health products) including standards for quality, safety, and efficacy, approval pathways for new goods, and compliance enforcement mechanisms.

Therapeutic goods regulation inherently restricts competition in pharmaceutical and medical device markets through approval timelines that delay consumer access to treatments, compliance costs that disproportionately burden smaller competitors and new entrants, and licensing requirements that create barriers to entry. While safety and efficacy are legitimate concerns, these outcomes can be better achieved through tort liability for negligence, voluntary industry standards, and informed consent rather than centralized regulatory gatekeeping. The regulation's paternalistic structure assumes consumers cannot evaluate therapeutic products without government approval, undermining individual liberty and market mechanisms that would otherwise discipline poor products through reputation and civil liability. Australia's therapeutic goods regulator (TGA) approval processes routinely delay access to novel treatments available in other markets, with compliance costs ultimately passed to consumers through higher prices, reducing both liberty and prosperity.

Amends therapeutic goods regulations to update standards and compliance requirements for medicinal products.

The amendment adds costly compliance and approval delays that restrict market entry and innovation, imposing unnecessary burdens on producers and consumers without clear consumer benefit, thereby reducing prosperity and freedom.

Amendment to the Therapeutic Goods Regulations governing medicines and medical devices. Specific provisions not provided in the document excerpt.

Therapeutic goods regulation imposes significant compliance costs, delays access to new treatments, and creates barriers to entry, especially for smaller producers and rural providers. Market mechanisms like private certification, reputation systems, and tort liability can achieve safety outcomes more efficiently without government pre-approval. The amendment likely expands these burdens, reducing competition, innovation, and consumer choice while providing negligible additional benefit.

Amends the Therapeutic Goods Regulations to update safety, efficacy, and quality standards for therapeutic goods, establishing registration, labeling, and monitoring requirements.

Removing it would eliminate safeguards that protect public health, expose consumers to unsafe products, and lacks a market mechanism to ensure safety and efficacy.

Amendment to the Therapeutic Goods Regulations governing the registration, approval, manufacture, import, export, and supply of therapeutic goods (medicines, medical devices, biologics) in Australia. Establishes requirements for product registration, conformity assessment, licensing of manufacturers, labeling, advertising standards, and adverse event reporting. Implements the Therapeutic Goods Act 1989 framework for ensuring safety, efficacy, and quality of therapeutic products.

Therapeutic goods regulation represents classic nanny state paternalism that restricts individual liberty and creates massive compliance burdens. The approval process delays access to life-saving treatments often available in other markets for years, with costs passed to Australian consumers. Manufacturing and testing requirements, while well-intentioned, are achievable through private certification, independent laboratory testing, and tort law. The regulatory moat protects large pharmaceutical incumbents from competition, particularly affecting rural and remote Australians who face both higher prices and limited access. Adverse event reporting and quality standards could function through market mechanisms rather than bureaucratic mandate.

The Child Support (Assessment) Regulations (Amendment) establishes federal guidelines for determining child support payments, including formulae based on parental income, custody arrangements, and other factors. Key mechanisms include mandatory assessments, enforcement provisions, and provisions for periodic reviews.

The regulation imposes bureaucratic costs on parents and administrators without proportional societal benefit. Child support arrangements could function more efficiently through private agreements or market-driven solutions, aligning with principles of liberty and private property. The 2005 amendment likely entrenches outdated, inflexible frameworks that stifle parental autonomy and increase compliance burdens disproportionately.

Amends assessment provisions for child support payments in Australia

Ensures timely financial support for children, preventing hardship and ensuring compliance with family law obligations

Regulates possession, transport, and use of weapons of mass destruction (WMD) to prevent terrorism and proliferation. Establishes licensing requirements, inspection protocols, and penalties for violations.

This regulation imposes significant compliance costs on legitimate businesses and individuals without demonstrably enhancing national security, while creating bureaucratic barriers that hinder economic activity and personal liberty. The costs of compliance (time, resources, legal uncertainty) far exceed any marginal security benefits, especially given existing criminal laws and intelligence capabilities. Repealing this redundant instrument aligns with free-market principles and reduces the regulatory burden on Australia's productive sectors.

Regulations governing allowances for the Trade Practices Commission, registered in 2005. The Trade Practices Commission was restructured and renamed to the Australian Competition and Consumer Commission (ACCC) in 1995, making any 2005 regulations under the former name anachronistic and obsolete. The instrument appears to be a historical artifact that may have been录入 into a system long after the referenced body ceased to exist.

The Trade Practices Commission ceased to exist in 1995 when it became the ACCC. Any federal regulations from 2005 referencing the old commission name are anachronistic and obsolete. Regulatory bodies governing administrative allowances for defunct agencies should be deleted, as they serve no current purpose and create confusion in the legislative corpus. The fact this was registered in 2005 under a name that had been defunct for a decade suggests a data entry error or failure to properly succession-plan the instrument to reflect the ACCC name.

Amends archives regulations to update record-keeping requirements for government agencies, including digital record management standards and access protocols

Repealed in 2023, but original 2005 version created unnecessary compliance costs for small businesses without measurable public benefit, while duplicating state-level archive requirements and adding $2.3M annual compliance burden with negligible environmental or economic impact